A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Dobutamine Impurity 12 - Request Quote

Picture of Dobutamine Impurity 12

Dobutamine Impurity 12

SZ CAT No:SZ-D095018
CAS No
NA
Mol.F.
C20H27NO3 : HCl
Mol.Wt.
329.4 : 36.5
Inv. Status
In Stock
Rel. CAS No334947-73-8 (free base)

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Dobutamine Impurity 12 is chemically 2-methoxy-5-(2-((4-(4-methoxyphenyl)butan-2-yl)amino)ethyl)phenol hydrochloride. Dobutamine Impurity 12 is supplied with detailed characterization data compliant with regulatory guideline. Dobutamine Impurity 12 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dobutamine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Dobutamine Impurity 12

Purchase Dobutamine Impurity 12

Dobutamine Impurity 12 suppliers

Dobutamine Impurity 12 manufacturers

Dobutamine Impurity 12 price

Order Dobutamine Impurity 12

Enquire Dobutamine Impurity 12

Dobutamine Impurity 12 cost

Dobutamine Impurity 12 Supplier

Dobutamine Impurity 12 Distributor

Dobutamine Impurity 12 for Method Validation

Dobutamine Reference Standard

Dobutamine Impurity 12 for ANDA Filing

Dobutamine Impurity 12 for Forced Degradation Studies

Dobutamine Impurity 12 Identification Standards

Dobutamine Impurity 12 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,